Stockreport

OS Therapies to spin off OS Animal Health into a standalone public company [Seeking Alpha]

OS Therapies Incorporated  (OSTX) 
PDF OSAH is the company's wholly owned subsidiary developing OST-HER2 for canine osteosarcoma. The company expects OSAH to become a standalone public company on a U.S. na [Read more]